
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf is well-positioned for long-term growth, with a strong presence in the banking and retail segments, excellent customer relationships, and a diverse geographic footprint. The company's recent acquisition of Wincor Nixdorf has added to its product line and geographic diversity, providing significant potential for cost synergies. Despite potential risks such as tariff-related costs and disruptions due to the COVID-19 pandemic, Diebold Nixdorf remains undervalued compared to its peers and offers a compelling investment opportunity with solid free cash flow generation and an attractive FCF yield.
Bears say
Diebold Nixdorf is supported by its strong balance sheet, with low net leverage of 1.2x and significant liquidity of $680M, as well as positive free cash flow of $21M in 1Q26. The company's ability to complete share buybacks and potential debt refinancing further adds to its financial flexibility. However, concerns remain about the Services margin and overall EBITDA cadence, leading to a cautious outlook and a $100 price target.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares